Component
Methylglyoxal
Methylglyoxal. Species, exposure and limitations are retained in each linked claim.
6 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Human GLO1 catalyzes glutathione-dependent methylglyoxal inactivation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/9218781.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e00867a8f693a2a0e6506a87d162a52ce4aa75ac846c7b0495dcf6ad7c9330e1", "start_char": 0, "end_char": 1251, "text_sha256": "e00867a8f693a2a0e6506a87d162a52ce4aa75ac846c7b0495dcf6ad7c9330e1"}
- experimental_model
- Human GLO1 crystal structure
- exposure
- S-benzyl-GSH complex
- limitations
- The essential zinc site is biochemical evidence; neither zinc nor GSH supplementation was tested.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human
- plain_language
- Glutathione also participates in handling a reactive carbonyl compound.
- primary_references
- [glutathione-p9218781] Crystal structure of human glyoxalase I--evidence for gene duplication and 3D domain swapping. (1997). https://pubmed.ncbi.nlm.nih.gov/9218781/ DOI: 10.1093/emboj/16.12.3386
- tissue_or_cell_type
- Purified dimeric enzyme
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 879–890
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human GLO1 crystal structure · source_derived_draft · unverified_draft
### glutathione-glo1-methylglyoxal Human GLO1 catalyzes glutathione-dependent methylglyoxal inactivation. Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: Glutathione also participates in handling a reactive carbonyl compound. organism: Human tissue_or_cell_type: Purified dimeric enzyme experimental_model: Human GLO1 crystal structure limitations: The essential zinc site is biochemical evidence; neither zinc nor GSH supplementation was tested. exposure: S-benzyl-GSH complex evidence_span: {"source_cache": "artifacts/glutathione-research/9218781.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e00867a8f693a2a0e6506a87d162a52ce4aa75ac846c7b0495dcf6ad7c9330e1", "start_char": 0, "end_char": 1251, "text_sha256": "e00867a8f693a2a0e6506a87d162a52ce4aa75ac846c7b0495dcf6ad7c9330e1"} [glutathione-p9218781] Crystal structure of human glyoxalase I--evidence for gene duplication and 3D domain swapping. (1997). https://pubmed.ncbi.nlm.nih.gov/9218781/ DOI: 10.1093/emboj/16.12.3386
Complete structured claim and evidence
Where it participates (unsigned role)
Ankaflavin increased glutathione measured in liver and pancreas of methylglyoxal-treated rats.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Four-week Wistar rat model.
- limitations
- Does not establish dietary cysteine demand, human glutathione repletion or which flux caused the concentration change.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- Glutathione connects this pigment to shared amino-acid-dependent defenses.
- primary_references
- [23022408] Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23022408/ · DOI 10.1016/j.freeradbiomed.2012.09.025
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 260–266
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Four-week Wistar rat model. · source_derived_draft · unverified_draft
## red-yeast-rice-ankaflavin-gsh Glutathione connects this pigment to shared amino-acid-dependent defenses. Ankaflavin increased glutathione measured in liver and pancreas of methylglyoxal-treated rats. Model: Four-week Wistar rat model. Limitations: Does not establish dietary cysteine demand, human glutathione repletion or which flux caused the concentration change. Evidence access: Primary abstract [23022408] Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23022408/ · DOI 10.1016/j.freeradbiomed.2012.09.025
Complete structured claim and evidenceGW9662 antagonism abolished tested insulin-sensitivity effects of ankaflavin in methylglyoxal-treated Wistar rats.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Four-week rat model; methylglyoxal 600 mg/kg and ankaflavin 10 mg/kg as reported.
- limitations
- Drug-induced rodent model; not an established treatment for human diabetes.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- Blocking the receptor helped test pathway involvement.
- primary_references
- [23022408] Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23022408/ · DOI 10.1016/j.freeradbiomed.2012.09.025
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 236–242
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Four-week rat model; methylglyoxal 600 mg/kg and ankaflavin 10 mg/kg as reported. · source_derived_draft · unverified_draft
## red-yeast-rice-ankaflavin-pparg-blockade Blocking the receptor helped test pathway involvement. GW9662 antagonism abolished tested insulin-sensitivity effects of ankaflavin in methylglyoxal-treated Wistar rats. Model: Four-week rat model; methylglyoxal 600 mg/kg and ankaflavin 10 mg/kg as reported. Limitations: Drug-induced rodent model; not an established treatment for human diabetes. Evidence access: Primary abstract [23022408] Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23022408/ · DOI 10.1016/j.freeradbiomed.2012.09.025
Complete structured claim and evidenceCarnosine also inhibited protein modification caused by products formed by incubating lysine with methylglyoxal.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free lysine-MG AGE preparation.
- limitations
- The study does not demonstrate removal of established tissue AGE deposits.
- nutrient_topic
- Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
- plain_language
- Protection was tested against secondary reaction products too.
- primary_references
- Carnosine protects proteins against methylglyoxal-mediated modifications. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9675080/ · DOI 10.1006/bbrc.1998.8806
Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 260–266
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Cell-free lysine-MG AGE preparation. · source_derived_draft · unverified_draft
## carnosine-mg-secondary Protection was tested against secondary reaction products too. Carnosine also inhibited protein modification caused by products formed by incubating lysine with methylglyoxal. Model: Cell-free lysine-MG AGE preparation. Limitations: The study does not demonstrate removal of established tissue AGE deposits. Evidence access: Primary abstract Carnosine protects proteins against methylglyoxal-mediated modifications. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9675080/ · DOI 10.1006/bbrc.1998.8806
Complete structured claim and evidenceAdding carnosine inhibited methylglyoxal-driven protein modification in electrophoretic assays.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free protein incubation.
- limitations
- Clinical glucose lowering is not established by this assay.
- nutrient_topic
- Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
- plain_language
- Another reactive carbonyl had less opportunity to modify proteins.
- primary_references
- Carnosine protects proteins against methylglyoxal-mediated modifications. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9675080/ · DOI 10.1006/bbrc.1998.8806
Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 252–258
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Cell-free protein incubation. · source_derived_draft · unverified_draft
## carnosine-mg-trapping Another reactive carbonyl had less opportunity to modify proteins. Adding carnosine inhibited methylglyoxal-driven protein modification in electrophoretic assays. Model: Cell-free protein incubation. Limitations: Clinical glucose lowering is not established by this assay. Evidence access: Primary abstract Carnosine protects proteins against methylglyoxal-mediated modifications. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9675080/ · DOI 10.1006/bbrc.1998.8806
Complete structured claim and evidenceHuman erythrocyte GLO1 forms S-D-lactoylglutathione through the methylglyoxal/GSH hemithioacetal intermediate.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/6863314.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fc40fe8d31ed36ad75af255cf31121d46ab8905d456f4ff9d94cc857e6b0e00d", "start_char": 0, "end_char": 2097, "text_sha256": "fc40fe8d31ed36ad75af255cf31121d46ab8905d456f4ff9d94cc857e6b0e00d"}
- experimental_model
- Forward/reverse enzyme kinetics
- exposure
- Lactoyl-GSH and thiol-trapping experiments
- limitations
- Artificial trapping reveals reversibility; it does not reverse the usual physiological net flux.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human erythrocyte enzyme; separate yeast comparison
- plain_language
- The first enzyme supplies the substrate processed by glyoxalase II.
- primary_references
- [glutathione-p6863314] Reversal of the reaction catalyzed by glyoxalase I. Calculation of the equilibrium constant for the enzymatic reaction. (1983). https://pubmed.ncbi.nlm.nih.gov/6863314/ DOI: 10.1016/s0021-9258(18)32137-9
- tissue_or_cell_type
- Purified glyoxalase I
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 918–929
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Forward/reverse enzyme kinetics · source_derived_draft · unverified_draft
### glutathione-glo1-product Human erythrocyte GLO1 forms S-D-lactoylglutathione through the methylglyoxal/GSH hemithioacetal intermediate. Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: The first enzyme supplies the substrate processed by glyoxalase II. organism: Human erythrocyte enzyme; separate yeast comparison tissue_or_cell_type: Purified glyoxalase I experimental_model: Forward/reverse enzyme kinetics limitations: Artificial trapping reveals reversibility; it does not reverse the usual physiological net flux. exposure: Lactoyl-GSH and thiol-trapping experiments evidence_span: {"source_cache": "artifacts/glutathione-research/6863314.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fc40fe8d31ed36ad75af255cf31121d46ab8905d456f4ff9d94cc857e6b0e00d", "start_char": 0, "end_char": 2097, "text_sha256": "fc40fe8d31ed36ad75af255cf31121d46ab8905d456f4ff9d94cc857e6b0e00d"} [glutathione-p6863314] Reversal of the reaction catalyzed by glyoxalase I. Calculation of the equilibrium constant for the enzymatic reaction. (1983). https://pubmed.ncbi.nlm.nih.gov/6863314/ DOI: 10.1016/s0021-9258(18)32137-9
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.